Freenome Holdings, Inc.: Biotechnology diagnostics company utilizing its deep expertise in molecular biology with advanced computational biology and machine learning techniques; the company pioneered a comprehensive multiomics platform for early cancer detection through a routine blood draw. $160M Series B led by RA and Polaris with Perceptive T. Rowe, Roche Ventures, Kaiser Permanente, and the American Cancer Society’s BrightEdge Ventures.
Sector/industry:
Healthcare/Medical Diagnostics & Research
Characteristics:
Based in...
US - Pacific
Disease Space
Oncology
Finance
Pre-Revenues
Industry
Diagnostics
Listing
Private
Market Cap
Private
Website:
Address:
259 East Grand Avenue
Suite 3434
South San Francisco, CA 94080
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.